Edward Lee Carter։ Stroke Prevention Starts in the Emergency Department – but Doesn’t End There
Edward Lee Carter, Clinical Pharmacist Practitioner at U.S. Department of Veterans Affairs, shared Emergency Medicine News’s post on LinkedIn about a recent article by Baldwin, published in Emergency Medicine News, adding:
”One of the most important moments in stroke prevention may occur in the Emergency Department.
Atrial fibrillation is increasingly encountered during acute care encounters, but initiating anticoagulation is often only the beginning of the challenge.
In real-world practice, the long-term success of anticoagulation frequently depends on what happens after discharge:
- patient understanding
- renal function follow-up
- medication affordability/access
- transitions of care
- peri-procedural planning
- coordination between clinicians
Underdosing DOACs ‘for safety’ when criteria are not met is another important issue that deserves continued attention, as inappropriate dose reduction may reduce efficacy without meaningfully improving outcomes.
Anticoagulation management is rarely just about selecting a drug.
It is about building a safe, understandable, sustainable plan for the patient.
That is where interdisciplinary care—including physicians, pharmacists, nurses, and patients themselves—can make a tremendous difference.”
Quoting Emergency Medicine News’s post:
”Atrial fibrillation is rising in the ED and early anticoagulation is one of the most impactful ways to prevent stroke. Current guidelines emphasize CHA₂DS₂‑VASc–based decisions, DOACs over warfarin, and correcting bleeding risks rather than withholding therapy.
Avoid underdosing (it raises stroke risk nearly 5 times), ensure patients understand their regimen, and remember: all cardioversion patients need at least 4 weeks of anticoagulation, regardless of method or timing.
ED clinicians are uniquely positioned to start stroke prevention at the moment it matters most.”
Title: Anticoagulation Strategies for Stroke Prevention in Atrial Fibrillation
Authors: Baldwin, Kendall PharmD Candidate, Hile, Kaitlin PharmD, BCCP, Hile, Garrett PharmD, BCEMP, BCCCP, Howington, Gavin T. PharmD, BCCCP, BCEMP

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 23, 2026, 17:51Gurpreet Kaurr: A Proud Milestone in Haematology and Oncology
-
Aug 23, 2026, 17:33Kathrine Kaspersen: How Voluntary Plasma Donors Helped Transform Denmark’s Plasma Supply
-
Aug 23, 2026, 16:51Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
-
Aug 23, 2026, 16:50Lale Tokgözoğlu: New PCSK9i Research Published in the European Heart Journal
-
Aug 23, 2026, 16:44Eric Gehrie: Your 2026 Guide to the Essentials of Transfusion Medicine
-
Aug 23, 2026, 16:35Thomas Dayspring: The Overlooked Pathway in Cholesterol Homeostasis
-
Aug 23, 2026, 16:28Evan Mapelu: The People Who Make Cancer Care Meaningful
-
Aug 23, 2026, 16:09Felice Gragnano: New Publication on Aspirin Discontinuation After PCI for Acute Coronary Syndromes
-
Aug 23, 2026, 16:06Mostafa Faisal: Donor Type and Long-Term Quality of Life After HCT for Severe Aplastic Anemia